Bill Barrett Corp. (BBG) Drops 5.63% on February 11

Equities Staff |

Bill Barrett Corp. (BBG) was one of the Russell 2000's biggest losers for Thursday February 11 as the stock slid 5.63% to $2.94, a loss of $-0.175 per share. Starting at an opening price of $3.06 a share, the stock traded between $2.70 and $3.06 over the course of the trading day. Volume was 1.07 million shares over 5,312 trades, against an average daily volume of 2.19 million shares and a total float of 49.96 million.

The losses send Bill Barrett Corp. down to a market cap of $146.63 million. In the last year, Bill Barrett Corp. has traded between $12.93 and $2.19, and its 50-day SMA is currently $3.97 and 200-day SMA is $5.83.

Bill Barrett Corporation is an oil and natural gas gas company engaged in the exploration, development and production of crude oil and natural gas.

Bill Barrett Corp. is based out of Denver, CO and has some 202 employees. Its CEO is R. Scot Woodall.

For a complete fundamental analysis analysis of Bill Barrett Corp., check out Equities.com’s Stock Valuation Analysis report for BBG. To see the latest independent stock recommendations from Equities.com’s analysts, visit our Research section.

The Russell 2000 is one of the leading indices tracking small-cap companies in the United States. It's maintained by Russell Investments, an industry leader in creating and maintaining indices, and consists of the smallest 2000 stocks from the broader Russell 3000 index.

Russell's indices differ from traditional indices like the Dow Jones Industrial Average (DJIA) or S&P 500, whose members are selected by committee, because they base membership entirely on an objective, rules based methodology. The 3,000 largest companies by market cap make up the Russell 3000, with the 2,000 smaller companies making up the Russell 2000. It's a simple approach that gives a broad, unbiased look at the small-cap market as a whole.

For more news on the financial markets, go to Equities.com. Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Comments

Emerging Growth

Beleave Inc.

Beleave Inc is a biotech company. The Company is engaged in the production of medical marijuana under the Marihuana for Medical Purposes Regulations outlined by Health Canada.

Private Markets

Knightscope

Autonomous security robots providing advanced detection capabilities at $7 per hour - aiming to define the future of security. Help #StopTheViolence.

Snapchat

Snapchat is the fastest way to share a moment with friends. The mobile app, allows users to not only share photos with friends but also control how long they can…